Tokyo, Japan

Saito Yutaka

This inventor holds 1 USPTO granted patent. Top assignee: Kyowa Hakko Kogyo Kabushiki Kaisha. Active years: 1992.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Saito Yutaka. Retrieved from https://idiyas.com/inventor/saito-yutaka

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile


% Patents Active = 100.0

Average Co-Inventor Count = 7.0

ph-index = 1

Forward Citations = 37(Granted Patents)


Company Filing History:


Years Active: 1992

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Saito Yutaka: Innovator in Mitomycin Derivatives

Introduction

Saito Yutaka is a prominent inventor based in Tokyo, Japan. He is known for his significant contributions to the field of pharmaceuticals, particularly in the development of mitomycin derivatives. His innovative work has led to advancements in cancer treatment options.

Latest Patents

Saito holds a patent for mitomycin derivatives, showcasing his expertise in medicinal chemistry. This patent represents a crucial step in enhancing the efficacy of cancer therapies.

Career Highlights

Saito Yutaka is affiliated with Kyowa Hakko Kogyo Kabushiki Kaisha, a leading company in the pharmaceutical industry. His role at the company has allowed him to focus on research and development, contributing to the advancement of medical science.

Collaborations

Saito has collaborated with notable colleagues, including Kono Motomichi and Sato Akira. Their teamwork has fostered a productive environment for innovation and research.

Conclusion

Saito Yutaka's work in mitomycin derivatives exemplifies the impact of dedicated inventors in the pharmaceutical field. His contributions continue to influence cancer treatment and improve patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…